AXSOME THERAPEUTICS INC's ticker is and the CUSIP is 05464T904. A total of 4 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,292 | -53.8% | 32,800 | -52.5% | 0.00% | -50.0% |
| Q2 2023 | $4,958 | -16.6% | 69,000 | -28.4% | 0.00% | -20.0% |
| Q1 2023 | $5,945 | -58.4% | 96,400 | -47.9% | 0.01% | -68.8% |
| Q4 2022 | $14,276 | -99.7% | 185,100 | +88.5% | 0.02% | +220.0% |
| Q3 2022 | $4,381,000 | -4.7% | 98,200 | -18.2% | 0.01% | 0.0% |
| Q2 2022 | $4,599,000 | +87.1% | 120,100 | +102.2% | 0.01% | +150.0% |
| Q1 2022 | $2,458,000 | -3.2% | 59,400 | -11.6% | 0.00% | -33.3% |
| Q4 2021 | $2,538,000 | +589.7% | 67,200 | +1144.4% | 0.00% | – |
| Q3 2021 | $368,000 | +1.1% | 5,400 | 0.0% | 0.00% | – |
| Q2 2021 | $364,000 | -26.0% | 5,400 | +6106.9% | 0.00% | -100.0% |
| Q1 2021 | $492,000 | – | 87 | -41.2% | 0.00% | – |
| Q4 2020 | $0 | – | 148 | -41.3% | 0.00% | – |
| Q3 2020 | $0 | – | 252 | -11.6% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 285 | -59.3% | 0.00% | -100.0% |
| Q1 2020 | $4,123,000 | -62.1% | 701 | -33.4% | 0.01% | -70.8% |
| Q4 2019 | $10,873,000 | +3116.9% | 1,052 | +529.9% | 0.02% | +2300.0% |
| Q3 2019 | $338,000 | -64.7% | 167 | -55.1% | 0.00% | -66.7% |
| Q2 2019 | $957,000 | -23.6% | 372 | -57.7% | 0.00% | 0.0% |
| Q1 2019 | $1,252,000 | – | 880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 600,000 | $26,772,000 | 4.71% |
| GROUP ONE TRADING, L.P. | 141,900 | $6,332,000 | 0.01% |
| SIMPLEX TRADING, LLC | 98,200 | $4,381,000 | 0.01% |
| JANE STREET GROUP, LLC | 181,600 | $8,103,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 2,200 | $98,000 | 0.00% |